Population health

Epidemiology

6 papers and 2 abstracts co-authored by Raphael E. Szalat. Current lab members are shown in bold.

Papers 6

  1. 2025

    Neighborhood disadvantage and multiple myeloma incidence in the Black Women’s Health Study

    Holder EX, Szalat R, Palmer JR, Bertrand KA

    International Journal of Epidemiology54(6)DOI: Neighborhood disadvantage and multiple myeloma incidence in the Black Women’s Health StudyPubMed: Neighborhood disadvantage and multiple myeloma incidence in the Black Women’s Health Study

  2. 2024

    Body size and risk of multiple myeloma in the Black Women’s Health Study

    Kataria Y, Pillalamarri BN, Zirpoli G, Szalat R, Palmer JR, Bertrand KA

    British Journal of Cancer130(5):830-835DOI: Body size and risk of multiple myeloma in the Black Women’s Health StudyPubMed: Body size and risk of multiple myeloma in the Black Women’s Health Study

  3. 2022

    Prevalence of monoclonal gammopathy of undetermined significance in US black women

    Bertrand KA, Zirpoli G, Pillalamarri BN, Szalat R, Palmer JR, Kataria Y

    American Journal of Hematology97(9)DOI: Prevalence of monoclonal gammopathy of undetermined significance in US black womenPubMed: Prevalence of monoclonal gammopathy of undetermined significance in US black women

  4. 2022

    Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study

    Fillmore NR, Szalat RE, La J, …, Munshi NC

    Proceedings of the National Academy of Sciences119(46)DOI: Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort studyPubMed: Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study

  5. 2020

    Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study

    Fillmore NR, La J, Szalat RE, …, Munshi NC

    JNCI: Journal of the National Cancer Institute113(6):691-698DOI: Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs StudyPubMed: Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study

  6. 2015

    Good Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune Complications

    Malphettes M, Gérard L, Galicier L, …, Szalat R, …, Oksenhendler E

    Clinical Infectious Diseases61(2):e13-e19DOI: Good Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune ComplicationsPubMed: Good Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune Complications

Abstracts & posters 2

  1. 2024

    Epidemiology and clinical characteristics of patients with monoclonal gammopathy of renal significance (MGRS) in a diverse population

    Granina E, Henderson J, Bertrand K, Sanchorawala V, Szalat R

    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS31:S135-S135

  2. 2023

    When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias

    Abdallah M, Arters F, Patel J, …, Szalat RE

    Blood142(Supplement 1):7432-7432DOI: When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias